Question from Deputy Pádraig Rice - PQ 40158-26
Deputy Rice asked about the reimbursement of Risdiplam for adults living with spinal muscular atrophy. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy Rice asked about the reimbursement of Risdiplam for adults living with spinal muscular atrophy. Read the HSE response.
Deputy O'Flynn asked if an audit has been conducted into value-for-money, expenditure controls or financial governance under the treatment abroad scheme.
Deputy O'Flynn asked about average cost of equivalent procedures between different EU/EEA healthcare systems under TAS. Read the HSE response.
Deputy O'Flynn asked if clinical outcomes, complication rates or patient satisfaction for patients availing of the treatment abroad scheme are collected.
Deputy McGuinness asked about the number of WTE consultant neurologists with a special interest in migraines and headaches based at UHW. Read the HSE response.
Deputy O'Flynn asked if the performance of agency staffing suppliers are monitored nationally. Read the HSE response.
Deputy O'Flynn asked if an agency or locum healthcare worker removed from one site can subsequently be redeployed elsewhere. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains a national supplier performance framework for healthcare staffing agencies. Read the HSE response.
Deputy O'Flynn asked if all treatment abroad scheme approvals are processed in the National Treatment Abroad Office in Kilkenny. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains a centralised national system relating to agency or locum healthcare workers across HSE-funded services.